Tempus Labs, Inc.

Tempus Ai, Inc.

Joshua Drews

Joshua S K Bell

Catherine Igartua

Hailey B Lefkofsky

Nike Tsiapera Beaubier

Lee F Langer

Joshua Sk Bell

Disclosed herein are systems, methods, and compositions useful for determining cellular pathway disruption comprising the use of RNA expression level information. This determined level of disruption can assist in the identification of genetic variants that alter pathway activity, to correlate these variants with disease state and disease progression, and to identify those therapeutics most likely to be effective and which should be avoided.

Systems and methods for detecting cellular pathway dysregulation in cancer specimens

Systems and methods are provided for performing quality control analysis. The method obtains, in electronic form, a batch dataset comprising, for each respective sample in a batch of samples, a corresponding plurality of sequence reads derived from the respective sample by targeted or whole transcriptome RNA sequencing and corresponding metadata for the respective sample. The method determines for the batch dataset a cohort-matched reference batch, where the cohort-matched reference batch is balanced for tissue site, tumor purity, cancer type, sequencer identity, or date sequenced. The method performs one or more global batch quality control tests on the batch dataset using at least the cohort-matched reference batch. The method removes respective samples from the batch dataset that fail any one of the one or more global batch quality control tests or flagging for manual inspection respective samples that fail any one of the one or more global batch quality control tests.

Systems and methods for automating RNA expression calls in a cancer prediction pipeline

Growing community of inventors

Chicago, IL, United States of America

Joshua Drews